Airborne-mediated microbial diseases such as influenza and tuberculosis represent major public 12 health challenges. A direct approach to prevent airborne transmission is inactivation of airborne 13 pathogens, and the airborne antimicrobial potential of UVC ultraviolet light has long been established; 14 however, its widespread use in public settings is limited because conventional UVC light sources are 15 both carcinogenic and cataractogenic. By contrast, we have previously shown that far-UVC light (207-16 222 nm) efficiently kills bacteria without harm to exposed mammalian skin. This is because, due to its 17 strong absorbance in biological materials, far-UVC light cannot penetrate even the outer (non living) 18 layers of human skin or eye; however, because bacteria and viruses are of micrometer or smaller 19 dimensions, far-UVC can penetrate and inactivate them. We show for the first time that far-UVC 20 2 efficiently kills airborne aerosolized viruses, a very low dose of 2 mJ/cm 2 of 222-nm light inactivating 21 >95% of aerosolized H1N1 influenza virus. Continuous very low dose-rate far-UVC light in indoor 22 public locations is a promising, safe and inexpensive tool to reduce the spread of airborne-mediated 23 microbial diseases. 24 25 3 Airborne-mediated microbial diseases represent one of the major challenges to worldwide public 26 health 1 . Common examples are influenza 2 , appearing in seasonal 3 and pandemic 4 forms, and bacterially-27
alternative to conventional 254-nm germicidal lamps to inactivate airborne microbes. Fig. 1 shows representative fluorescent 40x images of mammalian epithelial cells 50 incubated with airborne viruses that had been exposed in aerosolized form to far-UVC doses (0, 0.8, 1.3 51 or 2.0 mJ/cm 2 ) generated by filtered 222-nm excimer lamps. Blue fluorescence was used to identify the 52 total number of cells in a particular field of view, while green fluorescence indicated the integration of 53 live influenza A (H1N1) viruses into the cells. Results from the zero-dose control studies (Fig. 1, top 54 left) confirmed that the aerosol irradiation chamber efficiently transmitting the aerosolized viruses 55 through the system, after which the live virus efficiently infected the test mammalian epithelial cells. 56 Fig. 2 shows the surviving fraction, as a function of the incident 222-nm far-UVC dose, of 57 exposed H1N1 aerosolized viruses, as measured by the number of focus forming units in incubated 58 epithelial cells relative to unexposed controls. Linear regressions (see below) showed that the survival 59 results followed a classical exponential UV disinfection model with rate constant k=1.8 cm 2 /mJ (95% 60 confidence intervals 1.5-2.1 cm 2 /mJ). The overall model fit was good, with a coefficient of 61 determination, R 2 = 0.95, which suggests that most of the variability in virus survival was explained by 62 the exponential model. The rate constant of 1.8 cm 2 /mJ corresponds to an inactivation cross-section 63 (dose required to kill 95% of the exposed viruses) of D95 = 1.6 mJ/cm 2 (95% confidence intervals 1.4-1.9 64 mJ/cm 2 ).
66

Discussion
67
We have developed an approach to UV-based sterilization using single-wavelength far-UVC 68 light generated by filtered excilamps, which selectively inactivate microorganisms, but does not produce 69 biological damage to exposed mammalian cells and tissues [13] [14] [15] . The approach is based on biophysical 70 5 principles in that far-UVC light can traverse and therefore kill bacteria and viruses which are typically 71 micrometer dimensions or smaller, whereas due to its strong absorbance in biological materials, far-72 UVC light cannot penetrate even the outer dead-cell layers of human skin, nor the outer tear layer on the 73 surface of the eye.
74
Here we applied this approach to test the efficacy of the 222-nm far-UVC light to kill influenza 75 A virus (H1N1) carried by aerosols in a benchtop aerosol UV irradiation chamber, which generated 76 aerosol droplets of sizes similar to those generated by human coughing and breathing. Aerosolized 77 viruses flowing through the irradiation chamber were exposed to UVC emitting lamps placed in front of 78 the chamber window.
79
As shown in Fig. 2 , killing of influenza A virus (H1N1) by 222-nm far-UVC light follows a 80 typical exponential disinfection model, with an inactivation cross-section of D95 = 1.6 mJ/cm 2 (95% CI: 81 1.4-1.9). For comparison, using a similar experimental arrangement, but using a conventional 254 nm 82 germicidal UVC lamp, McDevitt et al. 19 found a D95 value of 1.1 mJ/cm 2 (95% CI: 1.0-1.2) for H1N1 83 virus. Thus as we 13,15 and others [16] [17] [18] reported in earlier studies for bacterial inactivation, 222-nm far-84 UVC light and 254-nm broad-spectrum germicidal light are quite similar in their efficiencies for viral 85 inactivation, the comparatively small differences presumably reflecting differences in nucleic acid 86 absorbance. However as discussed above, based on biophysical considerations and in contrast to the 87 known human health safety issues associated with conventional germicidal 254-nm broad-spectrum 88 UVC light, far-UVC light does not appear to be cytotoxic to exposed human cells and tissues in vitro or 89 in vivo [13] [14] [15] . 90 If these results are confirmed in other scenarios, it follows that the use of overhead low-level far-91 UVC light in public locations may represent a safe and efficient methodology for limiting the 92 transmission and spread of airborne-mediated microbial diseases such as influenza and tuberculosis. In 93 6 fact the potential use of ultraviolet light for airborne disinfection is by no means new, and was first 94 demonstrated more than 80 years ago 8, 20 . As applied more recently, airborne ultraviolet germicidal 95 irradiation (UVGI) utilizes conventional germicidal UVC light in the upper part of the room, with 96 louvers to prevent direct exposure of potentially occupied room areas 21 . This results in blocking more 97 than 95% of the UV radiation exiting the UVGI fixture, with substantial decrease in effectiveness 22 . By 98 contrast, use of low-level far-UVC fixtures, which are potentially safe for human exposure, could 99 provide the desired antimicrobial benefits without the accompanying human health concerns of 100 conventional germicidal lamp UVGI.
101
A key advantage of the UVC based approach, which is in clear contrast to vaccination 102 approaches, is that UVC light is likely to be effective against all airborne microbes. For example, while 103 there will almost certainly be variations in UVC inactivation efficiency as different influenza strains 104 appear, they are unlikely to be large 7,10 . Likewise, as multi-drug-resistant variants of bacteria emerge, 105 their UVC inactivation efficiencies are also unlikely to change greatly 9 .
106
Finally it is of course by no means the case that all microbes are harmful, and it is well 107 established that the human microbiome is essential to human health 23 . With the exception of a subset of 108 the skin microbiome, all the human microbiome would be entirely shielded from far-UVC light due to 109 its very short range; in fact even within the skin biome only those biota on the skin surface 24 would be 110 potentially affected, which are of course the same biota that are potentially removed by hand 111 sanitizers 25 .
112
In conclusion, we have shown for the first time that very low doses of far-UVC light efficiently 113 kill airborne viruses carried by aerosols. For example, a very low dose of 2 mJ/cm 2 of 222-nm light 114 inactivates >95% of airborne H1N1 virus. Our results indicate that far-UVC light is a powerful and 115 inexpensive approach for prevention and reduction of airborne viral infections without the human health settings, determined the aerosol particle size distribution. An optimal RH value of 55% resulted in a 168 distribution of aerosol particle sizes similar to the natural distribution from human coughing and 169 breathing, which has been shown to be distributed around approximately 1 µm, with a significant tail of 170 particles less than 1 µm 36-38 . 171 After combining the humidity control inputs with the aerosolized virus, input flow was directed 172 through a series of baffles that promoted droplet drying and mixing to produce an even particle 173 distribution 34 . The RH and temperature inside the irradiation chamber were monitored using an Omega 174 RH32 meter (Omega Engineering Inc., Stamford, CT) immediately following the baffles. A Hal 175 Technologies HAL-HPC300 particle sizer (Fontana, CA) was adjoined to the irradiation chamber to 176 allow for sampling of particle sizes throughout operation.
177
During UV exposure, the three 222-nm lamps with filters were stacked vertically and placed 11 178 cm from the irradiation chamber window. The lamps were directed at the 26 cm × 25.6 cm chamber 179 window which was constructed of 254-µm thick UV transparent plastic film (Topas 8007X10, Topas 180 Advanced Polymers, Florence, KY), and which had a transmission of ~65% at 222 nm. The wall of the 181 irradiation chamber opposite the transparent window was constructed with polished aluminum in order 182 to reflect a portion of the UVC light back through the exposure region, therefore increasing the overall humidity of 55% which resulted in a particle size distribution of 87% between 0.3 µm and 0.5 µm, 11% 201 between 0.5 µm and 0.7 µm, and 2% > 0.7 µm. Aerosolized viruses were efficiently transmitted through Following three washes in HBSS ++ , the cells were stained with Vectashield containing DAPI (4',6- where k is the UV inactivation rate constant or susceptibility factor (cm 2 /mJ). The regression was 250 performed with the intercept term set to zero, which represents the definition of 100% relative survival 251 at zero UV dose. Bootstrap 95% confidence intervals for the parameter k were calculated using R 3.2.3 252 software 41 . The virus inactivation cross section, D95, which is the UV dose that inactivates 95% of the 253 exposed virus, was calculated as D95 = − ln[1 − 0.95]/k. 
